Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ipas
2. Isopropylideneazastreptonigrin
3. Imidazoquinoline
4. Azastreptonigrin, Isopropylidene-
5. Streptonigrin Tetrahydrooxime
6. Isopropylidine Azastreptonigrin
7. Nsc-62709
8. 15964-31-5
9. Streptonigrin, Tetrahydro-, Pseudooxime
10. Nsc62709
11. 0m3irn9cdj
12. 2-pyridinecarboxylic Acid, 5-amino-4-(2-hydroxy-3,4-dimethoxyphenyl)-6-(5-hydroxy-4-methoxy-2,2-dimethyl-2h-imidazo(4,5-h)quinolin-8-yl)-3-methyl-
13. Picolinic Acid, 5-amino-4-(2-hydroxy-3,4-dimethoxyphenyl)-6-(5-hydroxy-4-methoxy-2,2-dimethyl-2h-imidazo(4,5-h)quinolin-8-yl)-3-methyl-
14. Streptonigrin-aza, Isopropylidene
15. Isopropylidineazastreptonigrin
16. 5-amino-4-(2-hydroxy-3,4-dimethoxyphenyl)-6-(5-hydroxy-4-methoxy-2,2-dimethyl-2h-imidazo[4,5-h]quino
17. 5-amino-4-(2-hydroxy-3,4-dimethoxyphenyl)-6-(5-hydroxy-4-methoxy-2,2-dimethyl-2h-imidazo[4,5-h]quinolin-8-yl)-3-methylpyridine-2-carboxylic Acid
18. 5-amino-4-(2-hydroxy-3,4-dimethoxyphenyl)-6-(5-hydroxy-4-methoxy-2,2-dimethylimidazo[4,5-h]quinolin-8-yl)-3-methylpyridine-2-carboxylic Acid
19. Nsc 62709
20. Unii-0m3irn9cdj
21. Streptonigrin, Pseudooxime
22. 5-amino-4-(2-hydroxy-3,4-dimethoxyphenyl)-6-(5-hydroxy-4-methoxy-2,2-dimethyl-2h-imidazo(4,5-h)quinolin-8-yl)-3-methyl-2-pyridinecarboxylic Acid
23. Chembl1992147
24. Dtxsid50936143
25. Zinc4212044
26. Ccg-36191
27. Isopropylidene Azastreptonigrin
28. Nci60_008605
29. Picolinic Acid, 5-amino-4-(2,3-dihydro-3,4-dimethoxy-2-hydroxyphenyl)-6-(2,2-dimethyl-4-methoxy-5-oxo-5h-imidazo(4,5-h)quinolin-8-yl)-3-methyl-
30. 2-pyridinecarboxylic Acid,4-dimethoxyphenyl)-6-(5-hydroxy-4-methoxy-2,2-dimethyl-2h-imidazo[4,5-h]quinolin-8-yl)-3-methyl-
31. 5-amino-4-(2-hydroxy-3,4-dimethoxy-phenyl)-6-(5-hydroxy-4-methoxy-2,2-dimethyl-imidazo[4,5-h]quinolin-8-yl)-3-methyl-pyridine-2-carboxylic Acid
32. 5-amino-4-(2-hydroxy-3,4-dimethoxyphenyl)-6-(5-hydroxy-4-methoxy-2,2-dimethyl-2h-imidazo[4,5-h]quinolin-8-yl)-3-methyl-2-pyridinecarboxylic Acid #
33. Picolinic Acid,3-dihydro-3,4-dimethoxy-2-hydroxyphenyl)-6-(2,2-dimethyl-4-methoxy-5-oxo-5h-imidazo[4,5-h]quinolin-8-yl)-3-methyl-
34. Picolinic Acid,4-dimethoxyphenyl)-6-(5-hydroxy-4-methoxy-2,2-dimethyl-2h-imidazo[4,5-h]quinolin-8-yl)-
35. Picolinic Acid,4-dimethoxyphenyl)-6-(5-hydroxy-4-methoxy-2,2-dimethyl-2h-imidazo[4,5-h]quinolin-8-yl)-3-methyl-
| Molecular Weight | 545.5 g/mol |
|---|---|
| Molecular Formula | C28H27N5O7 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 6 |
| Exact Mass | 545.19104822 g/mol |
| Monoisotopic Mass | 545.19104822 g/mol |
| Topological Polar Surface Area | 182 Ų |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 1090 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
43
PharmaCompass offers a list of Imidazoquinoline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Imidazoquinoline manufacturer or Imidazoquinoline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imidazoquinoline manufacturer or Imidazoquinoline supplier.
PharmaCompass also assists you with knowing the Imidazoquinoline API Price utilized in the formulation of products. Imidazoquinoline API Price is not always fixed or binding as the Imidazoquinoline Price is obtained through a variety of data sources. The Imidazoquinoline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Imidazoquinoline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imidazoquinoline, including repackagers and relabelers. The FDA regulates Imidazoquinoline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imidazoquinoline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Imidazoquinoline supplier is an individual or a company that provides Imidazoquinoline active pharmaceutical ingredient (API) or Imidazoquinoline finished formulations upon request. The Imidazoquinoline suppliers may include Imidazoquinoline API manufacturers, exporters, distributors and traders.
Imidazoquinoline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Imidazoquinoline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Imidazoquinoline GMP manufacturer or Imidazoquinoline GMP API supplier for your needs.
A Imidazoquinoline CoA (Certificate of Analysis) is a formal document that attests to Imidazoquinoline's compliance with Imidazoquinoline specifications and serves as a tool for batch-level quality control.
Imidazoquinoline CoA mostly includes findings from lab analyses of a specific batch. For each Imidazoquinoline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Imidazoquinoline may be tested according to a variety of international standards, such as European Pharmacopoeia (Imidazoquinoline EP), Imidazoquinoline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Imidazoquinoline USP).
